Settings
MRK [NYSE]
Merck & Co. Inc.
IndexDJIA S&P500 P/E34.34 EPS (ttm)1.82 Insider Own0.04% Shs Outstand2.85B Perf Week0.99%
Market Cap178.15B Forward P/E17.81 EPS next Y3.51 Insider Trans-16.56% Shs Float2.85B Perf Month5.99%
Income5.39B PEG5.86 EPS next Q0.86 Inst Own75.20% Short Float0.99% Perf Quarter13.43%
Sales43.08B P/S4.14 EPS this Y-26.50% Inst Trans0.00% Short Ratio2.57 Perf Half Y8.96%
Book/sh15.71 P/B3.98 EPS next Y0.72% ROA5.20% Target Price64.66 Perf Year24.81%
Cash/sh5.03 P/C12.42 EPS next 5Y5.86% ROE11.10% 52W Range49.62 - 63.62 Perf YTD10.04%
Dividend1.80 P/FCF31.68 EPS past 5Y-16.50% ROI6.60% 52W High-1.26% Beta0.36
Dividend %2.88% Quick Ratio1.10 Sales past 5Y13.00% Gross Margin59.70% 52W Low26.61% ATR1.21
Employees77300 Current Ratio1.30 Sales Q/Q-4.30% Oper. Margin18.10% RSI (14)62.86 Volatility1.79% 1.88%
OptionableYes Debt/Eq0.62 EPS Q/Q-18.40% Profit Margin12.50% Rel Volume0.42 Prev Close62.49
ShortableYes LT Debt/Eq0.41 EarningsFeb 04 BMO Payout94.60% Avg Volume11.00M Price62.82
Recom2.40 SMA203.67% SMA505.19% SMA2008.71% Volume3,982,663 Change0.52%
Apr-30-14Reiterated Argus Buy $62 → $66
Apr-11-14Reiterated MKM Partners Buy $64 → $70
Feb-05-14Reiterated Argus Buy $54 → $62
Jan-14-14Reiterated MKM Partners Buy $59 → $64
Jun-03-13Reiterated MKM Partners Buy $54 → $59
Apr-15-13Reiterated Barclays Overweight $45 → $60
Feb-04-13Reiterated MKM Partners Buy $51 → $52
Feb-04-13Reiterated Barclays Overweight $46 → $45
Nov-20-12Upgrade MKM Partners Neutral → Buy $47 → $51
Oct-17-12Reiterated MP Advisors Outperform $45 → $50
Jul-30-12Reiterated UBS Buy $45 → $50
Jul-13-12Upgrade MP Advisors Market Perform → Outperform $45
Feb-03-12Reiterated Barclays Capital Overweight $38 → $40
Feb-03-12Downgrade MKM Partners Buy → Neutral $42 → $40
Nov-29-11Initiated MKM Partners Buy $38
Sep-14-11Reiterated Barclays Capital Overweight $41 → $38
May-16-11Reiterated UBS Buy $40 → $42
Feb-04-11Reiterated UBS Buy $42 → $40
Jan-24-11Reiterated Deutsche Bank Buy $48 → $43
Jan-24-11Reiterated Barclays Capital Overweight $43 → $41
Jan-26-15 08:31AM  Does Jerseys lagging economy doom Christies bid? at MarketWatch
08:30AM  Merck Announces CHMP Issues Positive Opinion for Investigational Antibiotic SIVEXTRO┬« (tedizolid phosphate) Business Wire
Jan-23-15 07:02AM  Dogs of the Dow can sniff out income at USA TODAY
01:00AM  First GSK Ebola vaccine shipment due to arrive in Liberia Reuters
Jan-22-15 04:51PM  NIH to Start Ebola Vaccine Study With Glaxo, Merck at The Wall Street Journal
03:29PM  Merck, on Behalf of its Wholly Owned Subsidiary, Cubist Pharmaceuticals, Announces Tender Offer for Cubists 2.50% Convertible Senior Notes Due 2017, 1.125% Convertible Senior Notes due 2018 and 1.875% Convertible Senior Notes due 2020 Business Wire
03:10PM  Celgene to Use Zymeworks' Azymetric Platform for New Drugs - Analyst Blog Zacks
08:14AM  We are funding part of ACA: Novartis CEO CNBC
Jan-21-15 06:03PM  Investment Bets On Antibiotics To Help Invigorate Investor Portfolios at Forbes
05:25PM  Merck Insiders' Planned Sales Hit $5.2 Million at Barrons.com
11:01AM  Merck Will No Longer Sell its Victrelis Hepatitis C Drug in the U.S. at The Wall Street Journal
08:00AM  Merck Completes Tender Offer to Acquire Cubist Business Wire
06:33AM  p53, Immunology and Antibody Drug Conjugate Therapies Bringing More Powerful Weapons to Battlefield in the War on Cancer Company Spotlight
Jan-20-15 06:06PM  Johnson & Johnson's forex warning a sign for rival drugmakers Reuters
05:45PM  Dana Holding Set to Join the S&P MidCap 400 PR Newswire
05:33PM  The 5 Best Dow Stocks So Far In 2015 Benzinga
04:52PM  Bristol-Myers Names New CEO at Barrons.com
03:30PM  Sanofi and Boehringer Ingelheim Ink Strategic Deal - Analyst Blog Zacks
11:30AM  Merck's 'not up for a big deal in 2015': Chair CNBC
09:00AM  East Bay's Depomed snags J&J pain-fighting drug in $1 billion deal at American City Business Journals
07:40AM  6 Ways to Trade Merck this Week Yahoo Finance Blogs
Jan-18-15 08:20AM  Merck Is Top DJIA Stock in 2015 at 24/7 Wall St.
Jan-16-15 03:12PM  Barclays Issues 3 Upgrades, 1 Downgrade On Pharma Stocks Benzinga
11:57AM  Merck Hires Ashley Watson As Compliance Head at The Wall Street Journal
09:19AM  Dow 30 Stock Roundup: JPM Results Disappoint, Microsoft Launches Affordable Handsets - Analyst Blog Zacks
Jan-15-15 12:30PM  Agilent Arm/Cell Signaling Tie for Companion Diagnostics - Analyst Blog Zacks
10:30AM  Healthcare Executives on a Saturday CNBC
12:01AM  Pfizer to Skip Melanoma in Bid to Join Cancer Race at Bloomberg
Jan-14-15 05:35PM  Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog Zacks
02:31PM  HALFTIME FINAL TRADES 1/14/15 at CNBC
02:00PM  Transforming medicine CNBC
09:30AM  Biopharma's challenges in 2015 CNBC
08:30AM  Practice Fusion Announces Positive Results of Population Health Vaccine Initiative Conducted in Collaboration with Merck PR Newswire
07:55AM  A New Dawn For Biotech? at Forbes
Jan-13-15 05:42PM  Top Cybersecurity Stock Qualys Gets Support at Investor's Business Daily
01:13PM  Midday movers: Aetna, Ocwen Financial, GoPro & more at CNBC
09:02AM  Lilly to test combinations with Merck, Bristol-Myers' cancer drugs Reuters
08:00AM  Merck Joins Messenger RNA Frenzy, Betting $100M On Moderna Therapeutics at Forbes
08:00AM  Lilly, Merck Enter Collaboration Agreement to Research Immuno-Oncology Combination Regimens in Multiple Types of Cancer Business Wire
Jan-12-15 05:02PM  Merck seeks new OK for cancer drug, reorganization on track AP
04:27PM  Merck CEO: Deals create value CNBC
03:34PM  Merck, Bristol heat up immunotherapy race in lung cancer Reuters
02:25PM  Bristol-Myers Hits 14-Year High On Cancer Drug Trial at Investor's Business Daily
12:16PM  Merck and Bristol-Myers Rivalry in Cancer Drugs Heats Up, Again at The Wall Street Journal
10:49AM  Merck Accelerates Lung Cancer, Hepatitis C Drugs at Bloomberg
08:08AM  Merck to Continue Focus on Cancer Drug Keytruda at The Wall Street Journal
07:52AM  Merck (MRK) Stock Higher Today as It Speeds Plans to Submit New Drugs at TheStreet
07:00AM  Merck Provides Update on Strategic Actions to Transform the Company and Build a Platform for Sustained Future Growth at the 33rd Annual J.P. Morgan Healthcare Conference Business Wire
02:49AM  More Rotavirus Vaccination Means Less Rotavirus at Forbes
01:50AM  Merck speeds up drug-submission plans for Hep C, lung cancer -WSJ Reuters
01:18AM  [$$] Merck Accelerates Drug-Submission Plans at The Wall Street Journal
Jan-11-15 11:04PM  Merck Accelerates Drug-Submission Plans at The Wall Street Journal
06:22PM  Shire to buy NPS for $5.2 billion at USA TODAY
Jan-09-15 08:00AM  Merck to Present at the 33rd Annual J.P. Morgan Healthcare Conference Business Wire
Jan-08-15 11:35AM  The Bullish and Bearish Case for Merck in 2015 at 24/7 Wall St.
08:02AM  5 Potential Blockbuster Drugs Set To Launch In 2015 at Investor's Business Daily
Jan-07-15 02:48PM  Stock Indexes Gun For Best Pop In 3 Weeks; Monster Breaks Out at Investor's Business Daily
08:20AM  Cramer's Outlook for Dow 30 Stocks, Part 2: JPMorgan to Wal-Mart at TheStreet
07:00AM  The Benefits and Costs of Socially Responsible Investing Morningstar
Jan-06-15 10:19AM  US stocks rise in rebound from rout; AOL jumps at CNBC
07:00AM  Theralase Anti-Cancer Technology Picks Up Steam Accesswire
02:21AM  J&J and Bavarian Nordic start clinical tests of Ebola vaccine Reuters
Jan-05-15 06:44PM  Dow and S&P Worst Day Since October 9th 2014 at Bloomberg
04:26PM  Not a pretty day on Wall Street... Yahoo Finance Blogs
10:42AM  Ebola Vaccine Tests Resume at The Wall Street Journal
08:00AM  Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4 Business Wire
07:53AM  Merck-NewLink Ebola vaccine trial resumes at lower dose -Geneva hospital Reuters
Dec-30-14 10:00AM  Are Placebos Ethical In Ebola Trials? at Forbes
Dec-29-14 01:55PM  Business events scheduled for Tuesday AP
Dec-26-14 04:00PM  Stocks extend holiday cheer: S&P, Dow end at records at CNBC
12:35PM  4 Potential Blockbuster Drugs The FDA Just Approved at Investor's Business Daily
Dec-24-14 09:23AM  Cramer's Mad Dash: Pharma movers CNBC
Dec-23-14 03:55PM  Sale of Sigma-Aldrich to Merck gets antitrust approval at bizjournals.com
10:43AM  Indexes Turn Mixed On Data; Celgene Dives at Investor's Business Daily
Dec-22-14 11:44AM  Merck Finally Gets Some Good News on Cubist at The Wall Street Journal
10:34AM  Stocks Struggle To Hold Gains; Alaska Air, Spirit Up at Investor's Business Daily
09:32AM  NewLink Genetics Surges 3% Following Ebola Contract News Benzinga
08:00AM  NewLink Genetics, Merck Collaboration to Manufacture Ebola Vaccine Candidate Supported by $30 Million Government Award GlobeNewswire
Dec-19-14 07:06PM  [$$] FDA Approves Cubist's Experimental Antibiotic Zerbaxa at The Wall Street Journal
06:34PM  FDA OKs Cubist antibiotic for serious infections AP
06:30PM  FDA Approves Second Cubist Antibiotic Of 2014 at Forbes
08:00AM  Merck Begins Tender Offer to Acquire Cubist Business Wire
06:49AM  The Ebola Treatment You Haven't Heard Of at Forbes
Dec-18-14 02:26PM  Cardiology Drugs Of The Year: New, Old, And Not-So-Funny at Forbes
12:16PM  Merck buys Swiss biotech with promising cancer drug AP
08:47AM  [$$] Merck Acquires OncoEthix for Up to $375 Million at The Wall Street Journal
07:30AM  Merck Acquires OncoEthix, a Privately Held Oncology Company Developing Novel BET Inhibitors for Hematological and Solid Cancers Business Wire
07:14AM  Call buyers take a dose of Merck optionMONSTER
05:45AM  Options Traders Buy the Pullback in Pharmaceuticals Giant Merck at TheStreet
Dec-15-14 04:01PM  The 4 Stocks That Weighed on Mondays Market at 24/7 Wall St.
11:00AM  Mosquito-Borne Dengue Targeted by Antibody With Hope for Vaccine at Bloomberg
08:24AM  The Zacks Analyst Blog Highlights: Chevron, Statoil, Merck, Boeing and General Electric Zacks
Dec-13-14 01:04PM  MERCK & CO., INC. Financials EDGAR Online Financials
Dec-12-14 11:54AM  Merck KGaA -- Moody's downgrades Merck KGaA's ratings to Baa1; negative outlook at Moody's
05:29AM  India caps prices of 52 more "essential" drugs - pricing authority Reuters
Dec-11-14 04:10PM  Merck Reveals Data from Breast Cancer Study on Keytruda Zacks
03:28PM  Experimental Trial of Merck Ebola Vaccine Suspended at The Wall Street Journal
02:25PM  Lilly Upgraded On 2 Potential Blockbuster Drugs at Investor's Business Daily
02:17PM  Human trial of experimental Merck Ebola vaccine is suspended at MarketWatch
12:14PM  [video]Merck Buys Cubist, Amazon's Auction Alternative & Cheerios New Flavor at TheStreet
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. The company's Pharmaceutical segment offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, immunology, infectious diseases, and others. This segment also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. Its Animal Health segment discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. The company's Consumer Care segment develops, manufactures, and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant sprays; and products for occasional constipation, frequent heartburn, and overactive bladder in women; foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has collaborations with AstraZeneca LP, Pfizer Inc., Samsung Bioepis Co., Ltd., Sanofi Pasteur S.A., and Sysmex Inostics GmbH. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schechter Adam HEVP & Pres-Global Human HealthJan 15Option Exercise41.1874,2003,055,57874,200Jan 15 03:55 PM
Schechter Adam HEVP & Pres-Global Human HealthJan 15Sale62.4874,2004,636,2240Jan 15 03:55 PM
FRAZIER KENNETH CChairman, President & CEOJan 09Option Exercise34.2012,874440,240360,322Jan 09 02:44 PM
FRAZIER KENNETH CChairman, President & CEOJan 09Sale62.478,840552,267351,482Jan 09 02:44 PM
FRAZIER KENNETH CChairman, President & CEODec 10Option Exercise34.2012,874440,240357,294Dec 10 05:59 PM
FRAZIER KENNETH CChairman, President & CEODec 10Sale60.009,846590,760347,448Dec 10 05:59 PM
Kuhlik Bruce NExe V-P & Gen CounselDec 08Option Exercise51.0250,0002,551,000178,467Dec 08 06:55 PM
Kuhlik Bruce NExe V-P & Gen CounselDec 08Sale62.0050,0003,100,000128,467Dec 08 06:55 PM
LAZARUS ROCHELLE BDirectorNov 26Option Exercise34.1410,000341,35014,595Nov 26 12:40 PM
LAZARUS ROCHELLE BDirectorNov 26Sale59.6310,000596,3004,595Nov 26 12:40 PM
WEEKS WENDELL PDirectorNov 24Option Exercise33.835,000169,1505,100Nov 25 07:08 PM
WEEKS WENDELL PDirectorNov 24Sale59.135,000295,663100Nov 25 07:08 PM
FRAZIER KENNETH CChairman, President & CEONov 10Option Exercise34.2012,875440,272354,420Nov 10 04:36 PM
FRAZIER KENNETH CChairman, President & CEONov 10Sale57.9810,000579,784344,420Nov 10 04:36 PM
DeLuca Richard R.EVP&Pres, Merck Animal HealthNov 02Option Exercise0.004,38704,387Nov 03 04:46 PM
FRAZIER KENNETH CChairman, President & CEOOct 10Option Exercise34.2012,875440,272351,440Oct 14 09:05 AM
FRAZIER KENNETH CChairman, President & CEOOct 10Sale59.739,895591,033341,545Oct 14 09:05 AM
FRAZIER KENNETH CChairman, President & CEOSep 10Option Exercise34.2012,875440,272348,379Sep 10 01:53 PM
FRAZIER KENNETH CChairman, President & CEOSep 10Sale60.489,814593,592338,565Sep 10 01:53 PM
FRAZIER KENNETH CChairman, President & CEOAug 11Option Exercise34.2012,875440,272345,562Aug 12 09:01 AM
FRAZIER KENNETH CChairman, President & CEOAug 11Sale57.0010,058573,306335,504Aug 12 09:01 AM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerAug 04Option Exercise45.3823,4001,061,82042,844Aug 05 09:56 AM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerAug 04Sale56.6428,6691,623,72014,175Aug 05 09:56 AM
REPRESAS CARLOS EDirectorAug 01Option Exercise35.195,000175,9505,500Aug 05 10:16 AM
FRAZIER KENNETH CChairman, President & CEOJul 10Option Exercise34.2012,876440,307351,474Jul 10 03:47 PM
FRAZIER KENNETH CChairman, President & CEOJul 10Sale58.039,987579,545341,487Jul 10 03:47 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJul 07Option Exercise30.01180,0475,403,278273,611Jul 08 02:16 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJul 07Sale59.16180,04710,650,93293,564Jul 08 02:16 PM
Deese Willie AExe V-P & Pres. MMDJun 27Option Exercise27.8572,2902,013,164178,512Jun 30 04:23 PM
Deese Willie AExe V-P & Pres. MMDJun 27Sale58.2672,2904,211,254106,222Jun 30 04:23 PM
Schechter Adam HEVP & Pres-Global Human HealthMay 14Sale55.9110,527588,5840May 14 02:48 PM
FRAZIER KENNETH CChairman, President & CEOMay 09Option Exercise34.2012,876440,307345,927May 13 03:56 PM
FRAZIER KENNETH CChairman, President & CEOMay 09Sale55.0010,220562,100335,707May 13 03:56 PM
Schechter Adam HEVP & Pres-Global Human HealthMay 04Option Exercise0.0019,147019,147May 06 04:03 PM
Golestani ClarkEVP & Chief Info OfficerMay 04Option Exercise0.002,05109,278May 06 04:02 PM
GRADDICK WEIR MIRIAN MExe V-P, HRMay 04Option Exercise0.009,300098,387May 06 04:02 PM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareMay 04Option Exercise0.005,470038,311May 06 04:02 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Option Exercise0.004,240011,999May 06 04:02 PM
Kuhlik Bruce NExe V-P & Gen CounselMay 04Option Exercise0.009,8470132,660May 06 04:02 PM
Rosenblatt MichaelExec V-P & Chief Med OfficerMay 04Option Exercise0.004,103026,720May 06 04:02 PM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerMay 04Option Exercise0.004,103020,828May 06 04:01 PM
Deese Willie AExe V-P & Pres. MMDMay 04Option Exercise0.007,6590109,671May 06 04:01 PM
FRAZIER KENNETH CChairman, President & CEOMay 04Option Exercise0.0041,0280351,522May 06 04:01 PM
HARRISON WILLIAM B JRDirectorApr 25Option Exercise47.235,000236,1506,400Apr 29 11:36 AM
FRAZIER KENNETH CChairman, President & CEOApr 10Option Exercise34.2012,876440,307320,541Apr 11 09:53 AM
FRAZIER KENNETH CChairman, President & CEOApr 10Sale57.2410,047575,108310,494Apr 11 09:53 AM
Kuhlik Bruce NExe V-P & Gen CounselApr 04Option Exercise39.90145,2255,794,929267,070Apr 04 05:07 PM
Kuhlik Bruce NExe V-P & Gen CounselApr 04Sale56.43145,2258,195,164121,845Apr 04 05:07 PM
Golestani ClarkEVP & Chief Info OfficerFeb 14Option Exercise48.246,375307,53012,036Feb 14 05:11 PM
Golestani ClarkEVP & Chief Info OfficerFeb 14Sale55.475,990332,2766,046Feb 14 05:11 PM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareFeb 13Option Exercise36.5649,7501,818,86071,457Feb 14 11:17 AM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareFeb 13Sale55.0443,8702,414,57027,587Feb 14 11:17 AM
FRAZIER KENNETH CChairman, President & CEOFeb 11Option Exercise48.2445,0002,170,800304,349Feb 11 05:34 PM
Canan JohnSr.V-P Finc-Global ControllerFeb 11Option Exercise48.2410,000482,40020,697Feb 11 05:07 PM
Schechter Adam HEVP & Pres-Global Human HealthFeb 11Option Exercise47.6518,000857,70518,000Feb 13 10:12 AM
Schechter Adam HEVP & Pres-Global Human HealthFeb 11Sale55.6118,0001,000,9350Feb 13 10:12 AM
FRAZIER KENNETH CChairman, President & CEOFeb 11Sale54.5241,5202,263,683262,829Feb 11 05:34 PM
Canan JohnSr.V-P Finc-Global ControllerFeb 11Sale55.7010,000557,00210,697Feb 11 05:07 PM
WEEKS WENDELL PDirectorFeb 10Option Exercise47.235,000236,1505,100Feb 11 03:41 PM
WENDELL PETER CDirectorFeb 10Option Exercise47.235,000236,1506,000Feb 11 03:48 PM
Deese Willie AExe V-P & Pres. MMDFeb 10Option Exercise48.2420,000964,800156,049Feb 11 03:54 PM
Deese Willie AExe V-P & Pres. MMDFeb 10Sale54.6850,0002,734,155106,049Feb 11 03:54 PM
WENDELL PETER CDirectorFeb 10Sale54.445,000272,1931,000Feb 11 03:48 PM
WEEKS WENDELL PDirectorFeb 10Sale54.265,000271,283100Feb 11 03:41 PM
Deese Willie AExe V-P & Pres. MMDJan 27Option Exercise47.7930,0001,433,700136,049Jan 28 10:09 AM